Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1802632-22-9
2. Ct-1812
3. Ct1812
4. 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol
5. 0661v34ntv
6. 2-tert-butoxy-4-(3-(5-methanesulfonyl-1-1,3-dihydro-isoindol-1-yl)-3-methyl-butyl)-phenol
7. Unii-0661v34ntv
8. Chembl4846092
9. Schembl16972400
10. Bdbm349547
11. Bcp30368
12. Ex-a2998
13. Zb1519
14. At24038
15. Hy-111669
16. Cs-0089606
17. Us10207991, Ex. Cpd. No. 62
18. A935876
19. Ct 1812; Ct1812;sigma-2 Receptor Antagonist 1
20. 2243184-39-4
21. 4-[3-methyl-3-(5-methylsulfonyl-1,3-dihydroisoindol-2-yl)butyl]-2-[(2-methylpropan-2-yl)oxy]phenol
Molecular Weight | 431.6 g/mol |
---|---|
Molecular Formula | C24H33NO4S |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 431.21302971 g/mol |
Monoisotopic Mass | 431.21302971 g/mol |
Topological Polar Surface Area | 75.2 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 678 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?